As the global biopharmaceutical industry continues to grow and evolve, companies are constantly facing pressures to focus on the patient as they improve the quality, efficacy, cost, and compliance of their life-saving products. A steady march of innovative new large molecule products are steadily coming into commercial production, but a whole new new generation of medicine is also on the way. Advanced Therapy Medicinal Products (ATMPs) including Cell and Gene Therapies (CGTs), are at the brink of creating the next and perhaps biggest industry sector pharmaceuticals have ever seen, and important decisions are being made right now about how today’s brightest minds are going to contribute to the shaping and maturing of this exciting and emerging new range of of patient-saving breakthroughs. There is so much to discuss!
The Biomanufacturing World Summit brings together the “who’s who” of biomanufacutring and technical operations executives, cutting-edge technology providers and media partners for North America’s premier biologics event.
Agenda at a Glance
- Industry Challenges and Opportunities
- Quality Culture
- Capacity Management
- Supply Chain Management
- New Processes and Technologies
- Working with External Partners
- The Rise of Cell and Gene Therapies and the Next Generation of Medicine
Who Should Attend?
- SVPs & VPs of Manufacturing, Quality & Supply Chain
- Operations Executives
- Directors of Manufacturing, Quality & Supply Chain
- Technology Executives
- Plant/Site Managers
In a landscape where manufacturing intersects with the dynamic fields of biotech and biometrics, the life science sector stands at the forefront of innovation. As the global biopharmaceutical industry undergoes continuous expansion and transformation, companies find themselves in a perpetual quest to prioritize patient well-being. This pursuit entails enhancing the quality, efficacy, cost-effectiveness, and compliance of the life-saving products they develop.
Within this intricate tapestry, the Biomanufacturing World Summit emerges as a pivotal event. This summit serves as a nexus, convening the luminaries of the pharmaceutical realm, the avant-garde technology providers, and media partners. This gathering solidifies its position as North America’s premier biologics event, uniting the “who’s who” of pharmaceutical executives and industry experts. This collaborative platform offers an unparalleled opportunity for knowledge exchange, innovation, and networking, enabling professionals to chart the course of biomanufacturing, biotech, and the broader life science landscape.
